Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients-Reference-Cited by-同舟云学术

Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients

Published:2014-09 Issue:5 Volume:3 Page:523-531
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Chu Dominic¹,Popovic Marko¹,Chow Edward¹,Cella David²,Beaumont Jennifer L²,Lam Henry¹,Nguyen Jasmine¹,Giovanni Julia Di¹,Pulenzas Natalie¹,Bedard Gillian¹,Bottomley Andrew³

Affiliation:

1. Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

2. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

3. European Organisation for Research & Treatment of Cancer Headquarters, Brussels, Belgium

Abstract

This review aims to compare and contrast the development, characteristics and validity of two widely used quality of life assessment tools in patients with prostate cancers: the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-PR25) and Functional Assessment of Chronic Illness Therapy (FACT-P). Both questionnaires present several strengths as well as some limitations in measuring the quality of life of prostate cancer patients. Each tool may be selected accordingly based on study design and needs.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer.14.41

Reference20 articles.

1. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index

2. Prostate cancer: how assessment of QoL can improve delivery of care

3. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: A prospective study

4. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Life Determinants in Patients with Metastatic Prostate Cancer: Insights from a Cross-Sectional Questionnaire-Based Study;Current Oncology;2024-08-26

2. How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial;European Urology Oncology;2024-08

3. Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study;Drugs in Context;2024-06-19

4. Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer;Advances in Therapy;2024-06-11

5. Effectiveness of dietetic care for cancer survivors in the primary care setting: A systematic review and meta-analysis of randomized controlled trials;Journal of Cancer Survivorship;2024-05-06